Bayer Makes AI Deal to Search for Heart Drug Clues in U.K. Health Data

(Bloomberg) -- Bayer AG entered a two-year agreement to use artificial intelligence to hunt for heart treatments using Sensyne Health Plc’s trove of U.K. health records.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.